BFC
CVS icon

Bedel Financial Consulting’s CVS Health CVS Stock Holding History

Bedel Financial Consulting’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,052
Closed -$106K – 351
2022
Q1 		$106K Sell
1,052
-155
-13% -$16.3K 0.03% 266
2021
Q4 		$125K Buy
1,207
+48
+4% +$4.44K 0.04% 247
2021
Q3 		$98K Hold
1,159
– – 0.03% 273
2021
Q2 		$97K Buy
1,159
+316
+37% +$25.9K 0.03% 277
2021
Q1 		$63K Sell
843
-21
-2% -$1.53K 0.02% 335
2020
Q4 		$59K Buy
864
+100
+13% +$6.5K 0.03% 293
2020
Q3 		$45K Sell
764
-3
-0.4% -$187 0.02% 312
2020
Q2 		$50K Sell
767
-512
-40% -$32.2K 0.03% 277
2020
Q1 		$76K Sell
1,279
-1,385
-52% -$92.5K 0.05% 218
2019
Q4 		$198K Sell
2,664
-50
-2% -$3.51K 0.11% 142
2019
Q3 		$171K Hold
2,714
– – 0.1% 153
2019
Q2 		$148K Sell
2,714
-183
-6% -$9.86K 0.09% 163
2019
Q1 		$156K Buy
2,897
+500
+21% +$30.9K 0.1% 151
2018
Q4 		$157K Buy
2,397
+42
+2% +$3.13K 0.11% 141
2018
Q3 		$173K Buy
2,355
+76
+3% +$5.43K 0.12% 151
2018
Q2 		$147K Buy
2,279
+267
+13% +$17.6K 0.11% 159
2018
Q1 		$125K Buy
+2,012
New +$144K 0.1% 176

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bedel Financial Consulting's CVS Position: Q2 2022 in Review

Bedel Financial Consulting sold out of CVS Health (CVS) in Q2 2022, closing a stake of 1,052 shares — an estimated $106K sold.

Bedel Financial Consulting first reported a position in CVS in Q1 2018 and held it in 17 quarters. The position peaked at $198K in Q4 2019. 2,307 funds tracked by Wall St. Rank hold CVS as of Q2 2022.

  • Bedel Financial Consulting reported no remaining CVS Health position as of Q2 2022 after selling out during the quarter.
  • Bedel Financial Consulting sold 1,052 CVS Health shares in Q2 2022, an estimated $106K.
  • Bedel Financial Consulting first reported a position in CVS Health in Q1 2018 and held it in 17 quarters.
  • Bedel Financial Consulting's CVS Health position peaked at $198K in Q4 2019.
  • 2,307 funds tracked by Wall St. Rank held CVS Health as of Q2 2022.

Based on Bedel Financial Consulting's 13F filing for Q2 2022, filed 4 Aug 2022.